Role of Th2 responses in the development of allergen-induced airway remodelling in a murine model of allergic asthma

British Journal of Pharmacology

Volumn 138, Issue 5, 2003, Pages 912-920

  Komai, Masato ^a   Tanaka, Hiroyuki ^a   Masuda, Taisei ^a   Nagao, Koichi ^a   Ishizaki, Masayuki ^a   Sawada, Masatsugu ^a   Nagai, Hiroichi ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Airway; Bronchial asthma; Goblet cell; Inflammation; Remodelling; Subepithelial fibrosis; T helper type 2 cells; Transforming growth factor 1

Indexed keywords

ACETYLCHOLINE; ALLERGEN; CD4 ANTIGEN; CD8 ANTIGEN; HYDROXYPROLINE; IMMUNOGLOBULIN E; INTERLEUKIN 13; MONOCLONAL ANTIBODY; OVALBUMIN; TRANSFORMING GROWTH FACTOR BETA;

AIRWAY REMODELLING; ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BRONCHUS HYPERREACTIVITY; CELL HYPERPLASIA; CONTROLLED STUDY; EOSINOPHIL; FIBROSIS; GOBLET CELL; HISTOLOGY; KNOCKOUT MOUSE; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE; TH2 CELL; TISSUE REPAIR;

ALLERGENS; ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; ASTHMA; BRONCHIAL HYPERREACTIVITY; FEMALE; INTERLEUKIN-4; LUNG; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; OVALBUMIN; RATS; SPLEEN; TH1 CELLS; TH2 CELLS;

EID: 0037349125     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705105     Document Type: Article

References (46)

1. ADELMANN-GRILL, B.C., HEIN, R., WACH, F., & KRIEG, T. (1987). Inhibition of fibroblast chemotaxis by recombinant human interferon gamma and interferon alpha. J. Cell Physiol., 130, 270-275.
2. AIKAWA, T., SHIMURA, S., SASAKI, H., EBINA, M. & TAKISHIMA, T. (1992). Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. Chest, 101, 916-921.
3. BLOBE, G.C., SCHIEMANN, W.P. & LODISH, H.F. (2000). Mechanisms of Disease: Role of Transforming Growth Factor β in Human Disease. N. Engl. J. Med., 342, 1350-1358.
4. BORDER, W.A. & NOBEL, N.A. (1994). Transforming growth factor β in tissue fibrosis. N. Engl. J. Med., 331, 1286-1291.
5. BROWN, P.J., GREVILLE, H.W. & FINUCANE, K.E. (1984). Asthma and irreversible airflow obstruction. Thorax , 39, 131-136.
6. CHIARAMONTE, M.G., DONALDSON, D.D., CHEEVER, A.W. & WYNN, T.A. (1999). An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J. Clin. Invest., 104, 777-785.
7. DE VRIES, J.E. (1998). The role of IL-13 and its receptor in allergy and inflammatory responses. J. Allergy Clin. Immunol., 102, 165-169.
8. DJUKANOVIC, R., ROCHE, W.R., WILSON, J.W., BEASLY, C.R., TWENTYMAN, O. & HOLGATE, S.T. (1990). The role of mucosal inflammation in asthma. Am. Rev. Respir. Dis., 142, 434-457.
9. DOUCET, C., BROUTY-BOYE, D., POTTIN-CLEMENCEAU, C., JASMIN, C., CANONICA, G.W. & AZZARONE, B. (1998). Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma. J. Clin. Invest., 101, 2129-2139.
10. ELIAS, J.A., JIMENEZ, S.A. & FREUNDLICH, B. (1987). Recombinant gamma, alpha, and beta interferon regulation of human lung fibroblast proliferation. Am. Rev. Respir. Dis., 135, 62-65.
11. FINKELMAN, F.D., KATONA, I.M., URBAN, J., HOLMERS, J.F., OHARA, J., TUNG, A.S., SAMPLE, J.V. & PAUL, W.E. (1988). IL-4 is required to generate and sustain in vivo IgE responses. J. Immunol. 141, 2335-2341.
12. FOSTER, P.S., HOGAN, S.P., RAMSAY, A.J., MATTHAEI, K.I. & YOUNG, I.G. (1996). Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183, 195-201.
13. FOSTER, P.S., MING, Y., MATTHEI, K.I., YOUNG, I.G., TEMELKOVSKI, J. & KUMAR, R.K. (2000). Dissociation of inflammatory and epithelial responses in a murine model of chronic asthma. Lab. Invest., 80, 655-662.
14. + T-lymphocytes regulate airway remodeling and hyperreactivity in a mouse model of chronic asthma. Lab. Invest., 82, 455-462.
15. + T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am. J. Respir. Cell Mol. Biol., 10, 587-593.
16. GHOSH, A.K., YUAN, W., MORI, Y., CHEN, S.J. & VARGA, J. (2001). Antagonistic regulation of type I collagen gene expression by interferon-gamma and transforming growth factor-beta: integration at the level of p300/CBP transcriptional coactivators. J. Biol. Chem., 276, 11041-11048.
17. GRÜNIG, G., WARNOCK, M., WAKIL, A.E., VENKAYYA, R., BROMBACHER, F., RENNICK, D.M., SHEPPARD, D., MOHRS, M., DONALDSON, D.D., LOCKSLEY, R.M. & CORRY, D.B. (1998). Requirement for IL-13 independently of IL-4 in experimental asthma. Science, 282, 2261-2263.
18. HAYASHI, H., ABDOLLAH, S., QIU, Y., CAI, J., XU, Y.Y., GRINNELL, B.W., RICHARDSON, M.A., TOPPER, J.N., GIMBRONE JR. M.A., WRANA, J.L. & FALB, D. (1997). The MAD-related protein Smad7 associates with the TGF-β receptor and functions as an antagonist of TGF-β signaling. Cell, 89, 1165-1173.
19. HEARD, B.E. & HOSSAIN, S. (1973). Hyperplasia of bronchial muscle in asthma. J. Pathol., 110, 319-331.
20. HELDIN, C.H., MIYAZONO, K. & TEN DIJKE, P. (1997). TGF-β signalling from the membrane to the nucleus through SMAD proteins. Nature, 390, 465-473.
21. JEFFERY, P.K., GODFREY, R.W., ÄDELROTH, E., NELSON, F., ROGERS, A. & JOHANSSON, S.A. (1992). Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma: a quantitative light and electron microscopy study. Am. Rev. Respir. Dis., 145, 890-899.
22. KIVIRIKKO, K.I., LAITINEN, O. & PROCKOP, D.J. (1967). Modifications of a specific assay for hydroxyproline in murine. Annal. Biochem., 19, 249-255.
23. KOBAYASHI, T., MIURA, T., HABA, T., SATO, M., SERIZAWA, I., NAGAI, H. & ISHIZAKA, K. (2000). An essential role of mast cells in the development of airway hyperresponsiveness in a murine asthma model. J. Immunol., 164, 3855-3861.
24. KON, O.M., SIHRA, B.S., COMPTON, C.H., LEONARD, T.B., KAY, A.B. & BARNES, N.C. (1998). Randomised, dose-ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthma. Lancet. 352, 1109-1113.
25. KOPF, M., LE GROS, G., BACHMANN, M., LAMERS, M.C., BLUETHMANN, H. & KOHLER, G. (1993). Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature, 362, 245-248.
26. LEE, C.G., HOMER, R.J., ZHU, Z., LANONE, S., WANG, X., KOTELIANSKY, V., SHIPLEY, J.M., GOTWALS, P., NOBLE, P., CHEN, Q., SENIOR, R.M. & ELIAS, J.A. (2001). Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J. Exp. Med., 194, 809-821.
27. LOPEZ, A.F., SANDERSON, C.J., GAMBLE, J.R., CAMPBELL, H.D., YOUNG, I.G. & VADAS, M.A. (1988). Recombinant human interleukin 5 is a selective activator of human eosinophil function. J. Exp. Med., 167, 219-224.
28. MCKENZIE, A.N., CULPEPPER, J.A., DE WAAL MALEFYT, R., BRIERE, F., PUNNONEN, J., AVERSA, G., SATO, A., DANG, W., COCKS, B.G., MENON, S., DE VRIES, J.E., BANCHEREAU, J. & ZURAWSKI, G. (1993). Interleukin 13, a T-Cell-Derived Cytokine that Regulates Human Monocyte and B-Cell Function. Proc. Natl. Acad. Sci. U.S.A., 90, 3735-3739.
29. MINSHALL, E.M., LEUNG, D.Y.M., MARTIN, R.J., SONG, Y.L., CAMERON, L., ERNST, P. & HAMID, Q. (1997). Eosinophil-associated TGF-β1 mRNA expression and airways fibrosis in bronchial asthma. Am. J. Respir. Cell Mol. Biol., 17, 326-333.
30. NAGAI, H., MAEDA, Y. & TANAKA, H. (1997) The effect of anti-IL-4 monoclonal antibody, rapamycin and interferon-γ on airway hyperreactivity to acetylcholine in mice. Clin. Exp. Allergy, 27, 218-224.
31. + T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. Am. Rev. Respir. Dis., 146, 374-377.
32. NAKAO, A., FUJII, M., MATSUMURA, R., KUMANO, K., SAITO, Y., MIYAZONO, K. & IWAMOTO, I. (1999). Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J. Clin. Invest., 94, 5-11.
33. NOBEN-TRAUTH, N., KROPF, P. & MULLER, I. (1996). Susceptibility to Leishmania major infection in interleukin-4-deficient mice. Science, 271, 912-913.
34. PADRID, P., SNOOK, S., FINUCANE, T., SHIUE, P., COZZI, P., SLOWAY, J. & LEFF, A.R. (1995). Persistent airway hyperresponsiveness and histologic alterations after chronic antigen challenge in cats. Am. J. Respir. Crit. Care Med., 151, 184-193.
35. ROBINSON, D.S. (2000). Th-2 cytokines in allergic disease. Br. Med. Bull., 56, 956-968.
36. ROCHE, W.R., WILLIAMS, J.H., BEASLY, R. & HOLGATE, S.T. (1989). Subepithelial fibrosis in the bronchi of asthmatics. Lancet, 1, 520-524.
37. TANAKA, H., MASUDA, T., TOKUOKA, S., KOMAI, M., NAGAO, K., TAKAHASHI, Y. & NAGAI, H. (2001). The effect of allergen-induced airway inflammation on airway remodeling in murine model of allergic asthma. Inflamm. Res., 50, 616-624.
38. TEMANN, U.A., PRASAD, B., GALLUP, M.W., BASBAUM, C., HO, S.B., FLAVELL, R.A. & RANKIN, J.A. (1997). A novel role for murine IL-4 in vivo: induction of MUC5AC gene expression and mucin hypersecretion. Am. J. Respir. Cell Mol. Biol., 16, 471-478.
39. ULLOA, L., DOODY, J. & MASSAGUE, J. (1999). Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. Nature, 397, 710-713.
40. VIGNOLA, A.M., CHANEZ, P., CHIAPPARA, G., MERENDINO, C., PACE, E., RIZZO, A., ROCCA, A.M., BELLIA, V., BONSIGNORE, G. & BOUSQUEST, J. (1997). Transforming growth factor-β expression in mucosal biopsies in asthma and chronic bronchitis. Am. J. Respir. Crit. Care Med., 156, 591-599.
41. WILLS-KARP, M., LUYIMBAZI, J., XU, X., SCHOFIELD, B., NEBEN, T.Y., KARP, C.L. & DONALDSON, D.D. (1998). Interleukin-13: central mediator of allergic asthma. Science, 282, 2258-2261.
42. WILSON, J.W. (1998). What causes airway remodeling in asthma? Clin. Exp. Allergy, 28, 534-536.
43. YAMAGUCHI, Y., SUDA, T., SUDA, J., EGUCHI, M., MIURA, Y., HARADA, N., TOMINAGA, A. & TAKATSU, K. (1988). Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J. Exp. Med., 167, 43-56.
44. ZIESCHE, R., HOFBAUER, E., WITTMANN, K., PETKOV, V. & BLOCK, L.H. (1999). A preliminary study of long-term treatment with interferon gamma-1β and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N. Engl. J. Med., 341, 1264-1269.
45. ZHU, Z., HOMER, R.J., WANG, Z., CHEN, Q., GEBA, G.P., WANG, J., ZHANG, Y. & ELIAS, J.A. (1999). Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest., 103, 779-788.
46. ZUHDI ALIMAM, M., PIAZZA, F.M., SELBY, D.M., LETWlN, N., HUANG, L. & ROSE, M.C. (2000). Muc-5/5ac mucin messenger RNA and protein expression is a marker of goblet cell metaplasia in murine airways. Am. J. Respir. Cell Mol. Biol., 22, 253-260.